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ABSTRACT
PERIPHERAL PARASITE DENSITY AND ITS RELATIONSHIP TO SEVERITY OF
DISEASE IN PEDIATRIC CEREBRAL MALARIA. Rachel N. Bronzan. Kilifi Coastal
Unit, Kenya Medical Research Institute, Kilifi, Kenya. (Sponsored by Frank J. Bia,
Department of Medicine, Yale University School of Medicine, New Haven, CT).

Pediatric cerebral malaria is an important cause of pediatric mortality in sub-Saharan
Africa. Many efforts have been made to determine risk factors for serious disease and to
elucidate prognostic indicators, but studies to date have generally shown little or no
correlation between peripheral parasite density and severity of disease or outcome. This
study attempts to further define the relationship between parasite density and disease,
specifically investigating the interactions of age, parasite density, and mortality in cases
of cerebral malaria versus noncerebral malaria patients. Our data set is larger than any
which has been previously analyzed, and includes peripheral parasite counts on 3281
children ages 0 to 13 years, including 2212 inpatients (419 cerebral malaria, 1257 severe
noncerebral malaria, and 479 anemic patients), 438 outpatients, and 631 healthy children
from the community. For each group of patients, the geometric mean parasite density at
each age was determined and parasite densities were compared among groups. Mortality
was analyzed as a function of both age and parasite density for each group, and the
parasite densities for those who died were compared with the counts of those who
survived for each group. Parasite density was slightly positively correlated with age for
all groups analyzed together (r=0.09, pO.OOOl) and for noncerebral patients, but not for
other groups. Cerebral malaria and anemic patients' parasite densities tended to decrease
with age. Although inpatients with severe disease had significantly higher geometric
mean parasite densities as compared to other inpatients, cerebral and anemic patients had
significantly lower parasitemias than noncerebral patients with severe disease. Since
mortality is highest in the former two groups (cerebral patients 15.75% and anemic

patients 6.1%), peripheral parasite density alone at time of admission is clearly not of
prognostic value for death. Additionally, because of the wide range of parasite densities
within each group, parasite density is also not predictive of severe disease. Thus, this
study, more powerful than previous ones of its type, corroborates previous findings that
higher peripheral parasite density is grossly associated with worse prognosis but that
peripheral parasite density is of no prognostic value except at extremely high levels.
Modifiers of the parasite density/disease relationship and other determinants of morbidity
and mortality are discussed.
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INTRODUCTION
Malaria is a leading cause of morbidity and mortality in the developing world.
It has been estimated that there are 300 hundred million people infected with malaria
in the world and 100 million cases of malaria in developing countries each year [1]. In
children alone there are between 0.5 and 2 million deaths a year in sub-Saharan Africa
[2]. In malaria-endemic areas severe disease, characterized mostly by severe anemia and
cerebral malaria, is seen primarily in children and accounts for approximately 1-2% of
all malarial disease in children [2]. Cerebral malaria carries case fatality rates between 6
and 50% in the pediatric population, with many of those who survive having
permanent neurological sequelae [3, 20, 21, 22, 27, 28].
The pathogenesis and pathophysiology of cerebral malaria are not fully
understood. Sequestration of parasitized red blood cells (PRBCs) in the cerebral
vasculature of patients is strongly implicated in the pathogenesis of cerebral malaria,
but the pathophysiology of clinical disease is poorly understood. It has been shown,
however, that patients with cerebral malaria sequester more red blood cells (RBCs)
than do patients with other forms of malaria [4] and that the degree of PRBC
sequestration is strongly correlated with a clinical coma scale [5]. Whether the mass of
sequestered infected RBCs is directly a function of the total body parasite load, or
whether host-parasite interactions (i.e. specific interactions between infected red blood
cells and cerebral post-capillary endothelium) primarily determine the degree of
sequestration, has yet to be determined. If total body parasite load is correlated with
degree of sequestration, one might expect a strong positive association between high
peripheral parasitemias and cerebral malaria. If specific cell-cell interactions are a
strong determinant in the degree of sequestration, one could postulate at least a
weakening of such an association between parasitemia and disease. Certainly a
combination of factors contribute to sequestration and disease.
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Many efforts have been made to determine risk factors for serious disease and to
elucidate prognostic indicators. There have been varying reports on whether parasite
density correlates with severity of disease in patients without cerebral malaria, and
there are even fewer data concerning this potential correlation in patients with cerebral
malaria [3,14,18,38,11,16,35]. The goal of this study was to determine if there is a
correlation between high peripheral parasite counts and cerebral malaria in a malariaendemic area. We studied children in coastal Kenya who were infected with
Plasmodium falciparum and specifically examined the interrelationships between

parasite density, type and severity of clinical disease, age, and mortality.

Life Cycle of the Malaria Parasite
In order to understand the issues surrounding this study, it is necessary to
understand the life cycle of the malaria parasite in man. Plasmodium falciparum is the
most virulent of the four species of human malaria and is the sole focus of this study.
Infection with P. falciparum begins with the bite of an infected anophelene mosquito,
in our instance Anopheles gambiae. In the process of obtaining a blood meal, the female
mosquito deposits sporozoites into the host. The median size of this "dose" per bite is
approximately 20 sporozoites [6]. The sporozoites then pass to the liver where they
invade hepatocytes and multiply 10,000-fold over a period of about 8 to 9 days. The
parasites, now called merozoites, rupture from the hepatocytes and are released into
the bloodstream to invade erythrocytes of all ages. This begins the erythrocytic stage
of infection, the stage associated with disease [7].
Once inside the red blood cell the parasite develops through the stages of ring
form and trophozoite, and finally reproduces to form about 20 merozoites packed into
a schizont. The schizont eventually ruptures, releasing the merozoites into the
bloodstream, increasing the parasite population within the host. Less commonly the
parasite differentiates into gametocytes, the sexual form of the parasite. The parasite's
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life cycle is completed when a female mosquito takes another blood meal and ingests
the gametocytes, which are infectious for mosquitoes.
The entire cycle within the red blood cell transpires in 48 hours. During the
second half of the process, erythrocytes containing trophozoites adhere to the
endothelium of the post-capillary venules in the deep vascular beds of organs
throughout the body, a process known as sequestration. Consequently, only the
younger ring forms of the P. falciparum parasite are seen on examination of peripheral
blood [7].
Clinical Presentation of Malaria
The clinical presentation of malaria is varied. Symptoms of uncomplicated
malaria include fever, malaise, nausea, vomiting, and headache. However, in malariaendemic regions there is a high prevalence of asymptomatic parasitemia, so diagnosis of
malarial disease is not straightforward.

The presenting symptoms are shared with

many other common diseases, and the prevalence of parasitemia in people with fevers
can be expected to be at least that which is found in the general population [8].
Severe Disease: Presentation and Potential Risk Factors
In children, severe disease has two distinctive presentations, severe anemia and
cerebral malaria [8]. Severe disease occurs in a minority of children, but what
determines whether or not severe disease will develop is still poorly understood [2,8].
Hypoglycemia, convulsions, septicemia, retinal hemorrhages, elevated CSF lactate, and
hyperparasitemia (>20-25% cells parasitized [9,10]) are all associated with poor
prognosis [10]. In Malawi, Molyneux et al used a retrospective analysis to develop a
bedside prognostic index which identified those children with cerebral malaria who
were at increased risk for adverse outcome (death or neurologic sequelae) [3]. This
index included parasitemia >1 x 10^ ring forms/(ll, blood glucose <2.2 mmol/1, and
white blood cell count > 15 x 10^/1. Age has also been repeatedly shown to be a risk
factor not only for malarial disease but for severe malarial disease as well. Younger
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children have more clinical malaria episodes per year than do older ones. Interestingly,
although children under the age of one year are at highest risk for severe anemia, it is
those over the age of two who are at highest risk for cerebral malaria [7, 8]. This
unusual association of age with the spectrum of disease will be considered in more
detail later.
Severe anemia is attributable not only to the destruction of parasitized red
blood cells by the spleen but also to the destruction of nonparasitized red blood cells,
as well as to depressed erythropoeisis [23] The degree of anemia has often been
referred to as being disproportional to the level of parasitemia [24]. However, a recent
paper modeling the interaction between parasites and erythrocytes using coupled
differential equations, suggests that severe anemia can result from low parasitemia even
with constant erythropoeisis [23], Anemia is often severe enough to require
transfusion, and it is not uncommon for anemia to trigger heart failure.
The clinical features of cerebral malaria include a range of neurological findings,
and the diagnosis will vary with the clinical criteria being used [25]. In the research
setting coma scales are used to produce more uniform diagnoses, but rigorous inclusion
criteria may exclude true cases [8] while loose clinical definitions may lead to elevated
estimates of its incidence. Cerebral malaria is often characterized by sudden onset.
Clinical features include coma, seizures, and other neurologic findings such as gaze
abnormalities, retinal hemorrhages, and decorticate or decerebrate rigidity.
Postmortem pathologic examination of the brain often confirms the diagnosis of
cerebral malaria.
Although a positive blood smear helps to make the clinical diagnosis, it is
possible to have a transiently negative blood smear in a semi-immune person if an
infection is highly synchronized and the parasitized cells are all sequestered. Other
causes of coma and seizure confuse the picture. The Glasgow coma scale is poorly
suited to the assessment of coma in pediatric cerebral malaria patients. The Blantyre
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coma scale [3], developed in Blantyre, Malawi, is shown below and is far more
appropriate for assessing young children in coma because it does not require that
children be able to speak or follow commands. Additionally, children in malarial
coma often have consistently open eyes even in the absence of corneal reflexes,
indicating that this is not "spontaneous eye opening", yet these children would score
favorably on the Glasgow coma scale.
Blantyre Coma Scale
Best motor response
Localizes to painful stimulus
Withdraws limb from painful stimulus
No response or inappropriate response
Best verbal response
Cries appropriately with painful stimulus or, if
verbal, speaks
Moan or abnormal cry with painful stimulus
No vocal response to painful stimulus
Eye movement
Watches or follows (e.g. mother's face)
Fails to watch or follow

Score
2
1
0
2
1
0
1
0

A score of 0 in any of the three components of this coma scale is predictive of poor
outcome, but a combined score of 0 correlates more strongly with outcome [3].
Laboratory Diagnosis
Laboratory diagnosis of malaria typically involves the use of thick and thin
blood films. Although other diagnostic methods are available, such as polymerase
chain reaction, blood films are the most practical method available for use in the field.
Thick films employ larger samples of blood than do thin films and are therefore useful
in rapid screening for parasites. Preparation involves spreading out the blood on a
slide, allowing it to dry, and then lysing the red blood cells before staining. This
allows quantification of parasite density (parasites/pL blood) by calculating the
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number of parasites observed per 100 white blood cells and then multiplying by the
patient's white blood cell count.
For higher levels of parasitemia a thin blood film is the preferred method for
quantitative diagnosis. These films use a very thin layer of blood, and permit the
direct visualization of parasites within red blood cells. This allows the estimation of
the percent parasitemia (the percent of the total red blood cells which are infected) and
again permits calculation of the parasite density by counting the number of parasites
observed per 500 red blood cells and then multiplying by the patient's red blood cell
count.
Common laboratory findings in malaria include anemia, acid/base disturbances,
hypoglycemia, elevated CSF lactate, and elevated white blood cell count. The latter
three findings are associated with poor outcome. Acid/base disturbances,
hypoglycemia, and elevated CSF lactate in particular are common findings in cerebral
malaria.

Pathogenesis and Pathophysiology of Cerebral Malaria
As mentioned previously, the pathogenesis and pathophysiology of cerebral
malaria are poorly understood. The pathophysiology is probably related to
sequestration, cytoadherence of PRBCs to the cerebral vasculature, but the mechanisms
responsible for the pathology are not fully defined.

Risk factors for development of

cerebral malaria may be contributed by both the host and the parasite [2, 7]. For the
host these include HLA type, lack of immunity to certain strains of malaria parasites,
and sensitization by previous exposure [2, 7, 29]. For the parasite these include
exofactors (soluble parasite factors which may be toxins or may induce cytokine
production), ability to induce tumor necrosis factor (TNF), and capacity to bind to
endothelium and form rosettes [7, 26, 34]. These factors will be elaborated upon
further in the discussion.
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Sequestration is a process peculiar to Plasmodium falciparum in which infected
RBCs adhere to the endothelium of deep vascular beds and reduce blood flow. As
described, sequestration occurs about 24 hours into the 48 hour life cycle of the malaria
parasite. Mature trophozoites and schizonts are found sequestered in the deep vascular
beds of many different organs, while only ring stage parasites are found in the
peripheral blood. Sequestration can occur in any organ, but when it occurs in the
brain, cerebral malaria can result.
The process of sequestration clearly has some potential benefits for the parasite
[8], First, parasitized cells evade the spleen by residing in deep vascular beds. Second,
by obstructing blood flow sequestration produces a more hypoxic and acidic
environment which is beneficial to the asexual growth of the parasite. Third, it has
been postulated that sequestration provides for more efficient infection of new RBCs,
because newly released merozoites encounter a higher proportion of uninfected RBCs
when they enter the peripheral circulation [8].
On electron microscopic examination, parasitized red bloods cells exhibit small
protrusions on their cell membranes which are termed knobs. These knobs are
neoantigens, and have been shown to be parasite antigens which have been transported
to the cell membrane by the intracellular parasites [30], and they may also be modified
host RBC determinants [39]. In cerebral malaria it is these antigens which adhere to
various receptors on the endothelial cells of the cerebral vasculature, primarily the post
capillary venules, as well as to nonparasitized red cells (termed resetting) [7], both of
which probably contribute to the gross process of sequestration [31, 36].
Some neoantigens are highly conserved while others demonstrate the ability to
rapidly switch phenotypes, even in the absence of selective pressure [32]. The ability
to rapidly change these surface antigens could clearly be of importance in the parasite's
efforts to evade the host's immune response and this has implications for the
development of vaccines directed at intracellular stage parasites. Furthermore, it has

8

been demonstrated that the adhesive potential of these antigens changes with the
phenotype [32] which suggests a role for these changes in the pathogenesis of disease, a
role separate from immune evasion.
On the cerebral endothelium there are several candidate receptors for
parasitized RBC neoantigens including thrombospondin, CD36, ICAM-1, Eselectin, and vascular cell adhesion molecule-1 [7, 8]. The interaction of the
parasite surface antigen polymorphisms described above with host receptor
polymorphisms could result in extreme person-to-person variation in the
severity and type of disease [2]. These interactions will also be elaborated upon
in the discussion.

Peripheral Parasite Density and Disease
What is the relationship between peripheral blood parasite density and disease
severity? Parasite prevalence in a population and average parasite density in individuals
are indices which are often used to demonstrate malaria endemicity [8], But the
relationship of these factors to clinical disease has not been clearly demonstrated, so
their usefulness as surrogate measures of morbidity in the analysis of the effects of
various interventions is questionable.
It has been demonstrated in The Gambia that while clinical disease from
malaria shows striking seasonal variation, parasite prevalence varies little over the year,
suggesting that parasite prevalence does not correlate well with the amount of disease
in their population [15]. This illustrates the difficulties in distinguishing between
malarial infection and malarial disease. In Kenya a mean of approximately 33% of well
children had parasites on a thick smear [9]. In such a setting, a positive malaria blood
film in a patient with fever may be an incidental finding as the prevalence of
parasitemia in patients with fever will always be at least as high as the prevalence of
parasitemia in the general population. These kinds of data have led some researchers to
try to define a numerical cut-off level of parasitemia above which asymptomatic
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infection is uncommon [33, 15]. Exactly where this cut-off should fall is difficult to
determine. And as mentioned, severe disease does occur in patients with low, or even
transiently absent, parasitemias while patients with higher parasitemias can be
asymptomatic [14].
Age of the infected individual also influences the relationship between
parasitemia and disease. In malaria endemic regions, there is clearly a decrease in the
frequency and severity of disease at older ages where higher parasitemias are tolerated
without disease, suggesting that partial immunity may be established over time.
Although parasitemia occurs at all ages, the majority of symptomatic disease is seen in
children. Mortality from malaria is highest in children under the age of five, before the
age at which peak parasite prevalence is reached. Greenwood [15] and Molyneux [3]
have both found that in ill children parasite density does not correlate with age. In the
latter, study age <3 years was associated with poor outcome, demonstrating an effect of
age on disease which is independent of parasitemia.
Finally, only a few studies have specifically examined the relationship between
parasite density and severity of disease. Conclusions have been conflicting as to the
prognostic value of parasitemia at time of admission in predicting severity of disease or
outcome. In 1937, Field and Niven found a close correlation between mortality and
parasitemia, but only for those cases in which treatment was not given prior to doing
the blood smear. They also noted a >50% mortality in those patients with more than
500,000 parasites/pL [38]. These findings led to the acceptance and use of peripheral
parasitemia at time of admission as a gross indicator of morbidity and mortality. But
there have been many cases in the literature illustrating that very high parasitemias can
be tolerated without significant disease, and that severe disease or even death can occur
in the presence of very low parasite counts [14]. Field further supported the
correlation between parasitemia and mortality in 1949, and another study may
corroborate these findings [18]. A recent publication suggests that geometric mean
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parasite density in the general pediatric population can be used as a surrogate measure
of morbidity and mortality from malaria and would thus be a useful measure when
assessing various interventions, but this may only apply to mild forms of disease.
Molyneux et al [3] found an increased risk for adverse outcome such as death or
neurologic sequelae for those pediatric cerebral malaria patients with parasitemias over
lxl06/pL.
In 1949 Field noted that peripheral schizogony is associated with higher
parasitemias, yet felt that peripheral parasite density was of more prognostic value than
was peripheral schizogony. A mathematical model has been proposed and tested
which correlates higher proportions of late stage parasites in the peripheral blood with
degree of sequestration and thus severity of disease [12, 13].
Several studies found no correlation between admission parasitemia and
severity or type of disease [11, 16], although one study found that parasitemias in
asymptomatic people were significantly lower than those parasitemias associated with
disease [11]. Another study suggests that disease severity correlates better with the
sequestered parasite load than the number of circulating parasites [35]. Some of these
studies were limited by the number of patients (insufficient power) or the methods
used in collecting or analyzing data.
Our study attempts to further define the relationship between parasite density
and disease, looking specifically at the interactions of age, parasite density, and
mortality in cases of cerebral malaria versus noncerebral malaria and malarial anemia.
We examined our data to see if there was a difference in the mean parasite density in
cerebral malaria patients as compared to severely ill but noncerebral malaria patients
and additionally looked at mortality to see if it was associated with a higher
parasitemia when compared with children of the same age and disease status. Few if
any prior studies have had sufficient patient numbers to look at the association
between parasitemia and mortality.
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METHODS
Study Area, Population and Hospital
All patients in this study were from Kilifi District on the coast of Kenya. The
majority of the population are Giriama, members of the Mijikenda ethnic group. A
1989 national census estimated the total population of the district to be 63,834 persons,
79% of whom are rural farmers, the remaining 21% living in Kilifi town [9], Mosquito
vectors are present year-round and residents receive from 1.5 to 8 infective bites per
year in Kilifi town or the rural forest, respectively [41]. The parasite rate in healthy
children is 34% averaged over the year, but transmission peaks after the rainy season
when the parasite rate rises to 39%, remaining around 25% the rest of the year [9]. The
clinical picture of malaria is typical of that in an endemic area in that clinical disease
occurs primarily in children and malaria-specific mortality decreases with age, adults
having acquired sufficient immunity to remain asymptomatic when infected. A
minimum estimate of the incidence of severe malaria in children under 5 years is 14 per
1000 per year as estimated from hospital records [9]. The minimum estimate for the
malaria-specific mortality rate in children under five years is 1.1 per 1000 children per
year, but this is likely to be a significant underestimate because many deaths occur
outside the hospital [9],
The data for this study were collected over a period of five years, from January
1989 to December 1993, by researchers from the Kenya Medical Research Institute
(KEMRI) and by researchers from Oxford's John Radcliffe Hospital working in Kilifi.
Our study population was derived from four distinct patient populations: KEMRI
inpatients, pediatric ward patients, outpatient malaria cases, and healthy children from
the community. All children included in the study had a primary diagnosis of malaria.
Inpatients were from either the pediatric ward at Kilifi district hospital or the KEMRI
ward, a five-bed pediatric intensive care unit constructed to facilitate research on severe
pediatric malaria. The study included all patients admitted to either the KEMRI ward
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or the hospital pediatric ward from January 1989 to December 1991, and additionally
included all KEMRI patients admitted from January 1992 to December 1993.

Patients: Clinical Assessment and Laboratory Investigations
KEMRI patients were patients with severe malaria who were admitted to
KEMRI ward either immediately upon presentation to the hospital or on transfer from
the pediatric ward. Severe malaria was defined as having one or more of the following:
severe anemia (hb < 5.1g/dL) with parasitemia > 10,000/pL, prostration (unable to sit
or stand), cerebral malaria (coma defined as child unable to localize to pain [42] more
than one hour after a seizure and more than six hours after anticonvulsants),
hyperparasitemia (>20% parasitemia), 2 or more convulsions within 24 hours before
admission, and death with a diagnosis of malaria confirmed by blood film.
For the purpose of this study, children with severe malaria were classified as
either cerebral or noncerebral malaria patients. Patients with severe malaria were
considered noncerebral if they had a Blantyre coma score of 5. Cerebral malaria
patients were those children who could not localize to pain. Cerebral malaria patients
were divided into those who were cerebral on presentation (always cerebral) and those
who became comatose during their hospitalization (new cerebral). Throughout this
paper these two groups are analyzed together as cerebral malaria patients unless
otherwise specified. A subset of those severe noncerebral patients with a hemoglobin
less than 5.1g/dL were classified as anemic. Patients who were both anemic and
cerebral were classified only as cerebral.
On admission a complete history was taken from the parent and a physical
examination was performed. Multiple laboratory investigations and clinical
assessments were performed on admission as data was often being collected for other
investigative studies. Those data pertinent to this study include age in months, thick
blood films, thin blood films for those with high parasitemias, hemoglobin, white
blood cell count, red blood cell count, respiratory status (in respiratory distress, yes or
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no) and coma status (using Blantyre coma scale) [9]. At least every six hours during the
child's stay on the unit blood films were repeated and for those who were anemic or in
coma, hemoglobin or coma score was rechecked, respectively. Outcome was recorded
as dead, alive, or alive with neurologic sequelae.
Pediatric ward inpatients were those children who were admitted to the
pediatric ward by the hospital staff for inpatient therapy. Data available on these
patients consisted of age in months, admission blood film, blood count, and for some
patients, hemoglobin and repeat blood films as indicated. Outcome was recorded as
dead or alive.
The malaria outpatients were those who presented to the outpatient clinic at
the hospital and were subsequently recruited as nonsevere case controls for another
study [9]. Similarly, the sample of healthy children from the community was those
children selected as "well" community controls for the same study, all of whom had
blood films done. For these two groups of patients the child's age in months and the
parasite density at the time of the encounter were recorded.

Data Analysis
For most analyses children were divided into groups according to their age in years:
Age 0 years = 0 to 11 months
Age 1 year = 12 to 23 months
Age 2 years = 24 to 35 months
Age 3 years = 36 to 47 months
Age 4 years = 48 to 59 months
Age 5 years > 60 months
All children 6 years and older were included in the 5 year old age group because of
small sample size and the relatively similar spectrum of malaria disease and relative
"immunity" in these older children.
Parasite densities were calculated as explained previously. The number of
parasites per 100 white blood cells was multiplied by the white cell count times ten.
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The number of parasites per 500 red blood cells was multiplied by the red cell count
times 2,000. If a corresponding blood count had not been obtained simultaneously
with the blood film, the white or red cell count nearest in time to the blood film was
used.
For the outpatient malaria cases a cut-off of 10,000 parasites/pL was established
as a minimum cut-off for the diagnosis of clinical malaria in ambulatory children in an
effort to exclude ill children with incidental parasitemias. The natural log of the
parasite density (In parasitemia) was used for all analyses involving mean parasite
densities because of the right skew of the distribution of parasite densities. Admission
parasitemias were used for all calculations except where specified. For all summary
analyses "all inpatients" refers to all KEMRI and pedi ward patients from January 1989
to December 1991. Although KEMRI patients from 1992-1993 were also part of the
data set, summary statistics for inpatients are best represented by the complete set of all
inpatients from 1989-1991 as additional data in certain groups could skew the data. For
comparisons with other groups, "all inpatients" refers to all KEMRI and pedi ward
patients from 1989-1993.
For each group of patients the following statistics were calculated: mean age,
mean natural log of parasite density, geometric mean parasite density and mortality.
Mean parasitemias were compared between all possible pairs of groups. Each group
was analyzed both as a whole and after stratifying by age in years. Correlations
between parasitemia and age were assessed using linear regression.
Mortality for each group was compared with that of all other groups,
stratifying either by age or by level of parasitemia. Analysis of variance was utilized to
determine if mortality was affected by age, parasitemia or both. The parasitemia levels
used were, in parasites per flL blood: level 1 = 0-9,999 parasites, level 2= 10,000-49,999,
level 3 = 50,000-99,999, level 4=100,000-499,999, level 5 = 500,000-999,999, and
level 6>1,000,000 parasites. Additionally, the geometric mean parasitemias and
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mean In parasitemias were compared for the group of patients who died versus those
who survived.

Statistical Analysis
Statistical analysis was performed using SPSS for Windows (KEMRI Coastal
Unit, Kilifi, Kenya ) and STATA (Harvard School of Public Health). Multiple
ANOVA and linear regression were used for analysis of relationships between age or
mortality and parasitemia, t-test for unequal variances was used for comparison of
mean parasitemias and mean ages, and Spearman's correlation was used in the analysis
of some age/parasite relationships.

Terminology
For the purposes of this analysis, the following terminology will be used when
referring to the various patient groups unless otherwise specified (in order of severity):

Cerebral => KEMRI inpatients with cerebral malaria at any time
during admission
Always cerebral => KEMRI inpatients with cerebral malaria at
time of admission
Newly cerebral => KEMRI inpatients with cerebral malaria
which developed after admission
Noncerebral severe, or noncerebral KEMRI => KEMRI
inpatients with severe noncerebral malaria
Severe => all KEMRI inpatients
Anemic => Those noncerebral KEMRI patients with
hemoglobin < 5.1 g/dL
General pediatric ward, or pedi ward inpatients => inpatients on
the pediatric ward with disease serious enough to require
hospitalization but not necessarily meeting the
requirements for severe disease
All inpatients => Inpatients from all of the above groups
admitted between January 1989 and December 1991
Outpatients => Ambulatory children with malaria (parasitemia >
10,000 parasites/pL and clinical signs of malaria)
Healthy/well community children => Healthy children who had blood
films drawn for a previous study of parasite prevalence.

16

RESULTS
3281 children were studied of whom 2212 were inpatients, 438 were
outpatients diagnosed with malaria, and 631 were healthy children in the community.
Of the 2212 inpatients, 1676 had severe disease (admitted to KEMRI ward) and 536 had
been admitted to the general pediatric ward. Of the 1676 KEMRI patients, 419 had
cerebral malaria and the remaining 1257 had severe noncerebral malaria. 479 of the
KEMRI patients had severe malarial anemia, and 407 of these were not obtunded
(noncerebral).

Age Distribution
Ages ranged from 0 months to 157 months for all groups. The mean age for the
entire study population was 28.2 months. The mean age for cerebral malaria patients
was significantly higher than for anemic patients, 35.5 months versus 20.8 months
(p<0.0001, see Figures 1 and 2).

The mean age and age range for each group is shown

below.

Mean Age
(months)

Median Age
(months)

Range
(months)

All children

28.2

23

Oto 157

Inpatients:

27.1

21

Oto 157

Cerebral

35.5

32

4 to 157

Severe Noncerebral

25.3

19

Oto 148

27.6

21

Oto 148

20.8

13

1 to 149

20.5

12

1 to 121

Group

Noncerebral Nonanemic
Anemic
Noncerebral Anemic

24.7

19

0 to 127

Outpatients

Gen. Pedi Ward

28.8

25

2 to 90

Clinically well children

31.5

28

2 to 108

Parasite Densities and Prevalence
Among children diagnosed with malaria, parasite densities at time of admission
to the hospital ranged from 0 to 3,339,600 parasites/pL (not all patients had parasites
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on their first blood film after admission). Mean natural log parasite densities (mean In
parasitemias) and geometric mean parasitemias for each group were as follows:

mean
In para.

geomean
parasitemia

min. para,

max. para,

Group

number
of patients

(per pL)

(per pL)

all inpatients

1866

10.35

31,347

0

3,339,600

cerebral

419

10.48

35,562

0

3,339,600

noncerebral

1257

10.72

45,400

0

2,880,000

anemic

479

10.34

31,098

0

2,880,000

gen. pedi ward

536

9.80

18,092

0

999,999

outpatients

438

N/A*

N/A*

10,032

1,158,300

well children

631

2.5

12

0

50,406

* Not applicable because 10,000 parasites/pL cut-off was used
For the cross-section of 631 healthy children who had blood films done, the prevalence
of parasitemia was 33%.

Relation Between Age and Parasitemia
For the analysis of the relationship between parasite density and age, age was
analyzed using both age in months (a continuous variable) and age in years (analyzed as
both a continuous and categorical variable). For the group of all inpatients,
parasitemia was somewhat positively correlated with age (Spearman rank
coefficient = 0.090, p<0.0001). This linear correlation held for either age in years or
age in months as the explanatory variable. However, in analyzing any group on its
own (cerebral, noncerebral anemic, or general pediatric ward patients) only
noncerebrals and the subset of nonanemic noncerebrals showed statistically significant
correlations between parasite density and age (r = 0.069, p = 0,015 and r = 0.103,
p = 0.003, respectively, see Figure 3). This suggests that perhaps the slight correlation
seen for all age groups was a result of combining different patient populations which
had different mean parasitemias and different age distributions. For the outpatients,
parasitemia was not correlated with age (Figure 4), nor did the healthy children
demonstrate a trend toward lower parasite densities at older ages (Figure 5).
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Although there was no correlation between parasite density and age for all
severe cases taken together, when cerebral versus severe noncerebral disease were
compared, cerebral malaria patients' parasitemias tended to decrease with age
(p = 0.054) as compared with the parasitemias of patients with severe noncerebral
disease (Figure 6). For cerebral patients, then, we see a reversal of the direction of the
trend of parasitemia with age seen for the group of all inpatients. Because of the slight
correlation with age and the significantly different age distributions amongst the
different groups of patients, further analyses were done after stratifying by, or
otherwise controlling for, age.

Relation Between Parasite Density and Type or Severity of Disease
Cerebral disease versus other disease
The geometric mean parasitemias for cerebral versus noncerebral KEMRI
malaria patients were not significantly different (p = 0.201), nor were they different for
cerebral patients when compared with all other inpatients on both the KEMRI and
general pediatric wards (1989-1993). However, as mentioned above, the mean
peripheral admission parasitemia decreased with age for cerebral malaria patients.
Parasite density on admission was not significantly different for those children who
presented in coma (not localizing to pain) versus those who presented unobtunded
(Blantyre Coma Score = 5) independent of age (p = 0.46).
KEMRI inpatients versus others
The geometric mean parasitemia for KEMRI patients as a whole was
significantly different from that for general pediatric inpatients (p<0.00005). Taken
alone, both the cerebral and noncerebral KEMRI malaria groups had geometric mean
parasitemias which were significantly different from those of the general pediatric ward
patients. This was true for all ages taken together, but when analyzed by age in years,
we see an effect of age in that the mean parasitemias are not significantly different for
the three groups at the older ages, especially for the cerebral patients as compared to
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the general pediatric ward patients (Figure 7). This is due to the decreasing parasite
densities at older ages for the cerebral patients and slightly higher parasite densities for
the 4 and 5-year-old general pediatric was patients.
Anemic patients versus others
When the anemic patients were separated from and compared to other KEMRI
noncerebral patients who were not anemic, the anemic group had significantly lower
parasitemias than did the nonanemic noncerebral patients (p = 0.0021) however, the
cerebral patient's mean parasitemia was not significantly different from that of the
anemic patients (p = 0.4437). Similar to the cerebral patients, the anemic patients
demonstrated a trend toward lower parasitemias at older ages (p = 0.066, Figure 8).
Inpatients (1989-1991) versus others
Inpatients had dramatically higher parasitemias when compared with
outpatients, and an even greater difference was observed between inpatients and
healthy children (p < 0.0001).

Relation Between Mortality and Type or Severity of Disease
Mortality was significantly higher for the cerebral patients than for any other
group (15.75%). Anemic patients had the second highest mortality rate (6.1%) as
shown below. Mortality increased somewhat with parasitemia for each group except
for malaria outpatients (Figure 9). Additionally, for all groups, parasitemia was on
average higher for those children who died than for those who survived, but in no case
was the difference statistically significant (Figures 10, 11 and 12).

Patient Group
Gen. Pedi. Ward
Noncerebral
Cerebral
Anemic
All Inpatients

Geometric Mean

Geometric Mean

Parasitemia/jlL
Deaths

Parasitemia/|iL
Survivors

Mortality

23,389
81,634
51,534
53,637
48,533

18,034
44,356
33,190
30,031
30,638

1.87
3.18
15.75
6.14
4.61

Percent
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Mortality was approximately constant over all ages for all inpatients taken
together (Figure 13). Cerebral malaria patients had the highest mortality under 3 years
of age, and all anemic patients who dies were under 3 years of age (Figure 12).

DISCUSSION
It has long been accepted that there is a correlation between parasite load and
both severity of disease and outcome in Plasmodium falciparum malaria. What has not
been clearly described is the nature of these relationships for different presentations of
disease: cerebral malaria, severe anemia, and other presentations of variable severity.
Our data support previous findings that there is an association between parasite
density, as measured with a peripheral blood film at time of presentation, and severity
of disease, but we have also found that for those presentations of malarial disease with
the highest mortality (severe anemia, and particularly cerebral malaria) the association
with parasite density is weakest. Thus, peripheral parasite density is not of prognostic
value in predicting type or severity of disease or outcome for the individual patient.
Furthermore, our data suggest that peripheral parasite density may not be of use as a
surrogate measure of malaria-associated morbidity and mortality.

Parasitemia and Age in Severe Disease
Our data demonstrate a slight increase in peripheral parasitemia with increasing
age, for all inpatients evaluated from 1989-1991, but this trend was small. This
relationship was not significant for any group analyzed on its own.
There was a somewhat larger trend, of borderline significance, towards lower
parasitemias at older ages in both the cerebral and the anemic patients (p = 0.054 and
p = 066, respectively, Figure 6). While the relationship between parasite prevalence and
age in malaria-endemic areas has been well studied, there has been little research into
the relationship between parasite density and age. It has been well documented that
adults from endemic areas tolerate higher parasitemias without disease than do
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children, reflecting the development of immunity to malaria through repeated or even
chronic exposure. The nature and scope of this immunity are poorly understood and
there are several intriguing aspects to it. First, although the period of highest mortality
from malaria is from 0 to 5 years of age, parasite prevalence continues to rise until age
10, when mortality dramatically declines [2]. Second, although immunity apparently
builds over time, the average age of cerebral malaria patients is significantly higher than
the average age of severely anemic patients [2, 7], 36 versus 21 months from our data.
One theory which attempts to explain the first observation, that of decreasing
mortality in the face of increasing parasite prevalence, is the theory of strain-specific
immunity [37]. The authors suggest that immunity to P. falciparum parasites is strain
specific, and that immunity increases as children encounter each strain. Given a person
with an asymptomatic parasitemia, the argument is that the quantitative effects of a
new innoculum, i.e. the number of parasites contributed by a new bite at the beginning
of the rainy season, would be far outweighed by the numbers of parasites contributed
by multiplication of the preexisting parasites. Therefore, the authors propose that a
qualitative difference in the new innoculum, rather than the addition of many more
parasites, is what triggers disease. This theory is consistent with the observation that
vector control through the use of bednets has reduced morbidity and mortality
without reducing the prevalence of parasitemia. Although children are still parasitized,
bednets may reduce morbidity by reducing the number of infective bites per year,
because a lower infective bite rate most dramatically lowers the chances that a less
common event, such as being infected by a new strain of falciparum parasite, will occur

[6].
It is interesting to note that the age distributions for severe anemia and cerebral
malaria are significantly different from one another. The mean age for cerebral malaria
is 15 months older than that for severe malarial anemia in our study, and 18 months
older in two other studies in The Gambia and Kenya [43, 8]. This suggests that the
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pathophysiology of cerebral malaria is distinctly different from that of other forms of
malaria in that the partial immunity which children develop over time does not confer
the same protection from cerebral malaria as it does from other forms of disease.
Perhaps previous exposure actually sensitizes an individual and is a prerequisite to the
development of cerebral malaria [2]. Several other theories have been proposed to
explain the observed age distribution.
It has been suggested that there may be rarer, more virulent strains of malaria
which are more likely to cause cerebral malaria. In conjunction with the theory of
strain specific immunity, this would suggest that while young children are continually
challenged with the more common, less virulent strains, they do not develop
protective partial immunity to the virulent strains because on average, the population's
exposure to the virulent strains occurs at an older age. This theory would then
implicate parasite virulence factors in cerebral malaria.

Parasite Virulence Factors in Cerebral Malaria
Some proposed parasite virulence factors include increased ability to induce
tumor necrosis factor (TNF) production by the host, increased capability of binding to
endothelial cells, increased ability to form rosettes, and variable rates of replication
within the host [2, 7, 26, 34]. There is evidence to support some of these ideas.
Extracts of some strains of parasites induce higher levels of TNF-a than do other
strains [7], and higher levels of TNF have been found in the serum of patients with
cerebral versus other forms of malaria [34]. Thus, TNF is implicated in cerebral
disease and certain parasites are more capable than others of inducing TNF production.
Also, parasitized red blood cells (PRBCs) from patients with cerebral malaria show
varying degrees of binding to putative host cell receptors in vitro, suggesting that only
some strains of P. falciparum express neoantigens capable of cerebral cytoadherence
[44]. Additionally, some strains of P. falciparum do not produce knobs on the surface
of the PRBCs. These knobless PRBCs do not bind to endothelial receptors such as
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thrombospondin, suggesting that the ability to form knobs is another parasite
virulence factor [4, 31].

Host Factors in Severe Disease
Host factors are also likely to influence the likelihood of cerebral malaria or
other severe malaria disease. Variation in the host factors involved in cytoadherence
may contribute to a person's "susceptibility" to cerebral malaria. That is, amongst
individuals, differential expression of potential cerebral endothelial receptors for
infected RBC neoantigens may result in differential "susceptibility". Those persons
expressing more of the necessary receptors would experience cytoadherence,
theoretically leading to gross RBC sequestration and thus cerebral malaria. TNF has
been shown to upregulate I-CAM production, so a strain of parasite which was
particularly effective at inducing TNF production could "uncover" a person's
susceptibility to cerebral malaria by causing an upregulation of I-CAM or other
putative receptors which would increase binding. Some people may be more
susceptible to upregulation of this sort. Presumably, strain-specific immunity
developed over time protects adults even if they are individuals "susceptible" to
cerebral malaria.
Additionally, HLA type has been shown to play a protective role in malaria
disease [29]. In The Gambia there is a high frequency of HLA class I antigen HLABw53 which was associated with a 40% protection against both cerebral and severe
anemic disease, and HLA class II antigen DRwl3 was shown to be protective against
severe disease but not cerebral malaria. That HLA class I antigens are protective
against cerebral malaria but HLA class II antigens are not suggests that cytotoxic T-cell
actions may be involved in the killing of pre-erythrocytic parasites whereas antibodies
(produced in association with HLA class I antigens) may play a more important role in
the prevention of severe disease other than cerebral malaria [2]. Clearly, the details of
host-parasite interactions have not all been elucidated.
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Mortality
Although mortality was higher in both anemic and cerebral disease than in
other groups, the admission parasitemias of those who died were not significantly
higher than the parasitemias of those who survived for any group (Figures 11 and 12).
When all inpatients were considered together, those who died had a higher geometric
mean peripheral parasitemia than those who did not die (Figure 10). Mortality
increased in a linear fashion with increasing parasitemia for all KEMRI groups and for
all inpatients, but there was not a significant linear trend for the general pediatric ward
patients alone.
While peripheral parasite counts may be very useful in grossly determining
who is at higher risk of death they are not useful for predicting clinical course or
severity of disease, although it may be possible to establish cut-offs of parasite density
within various categories of disease which may be of some prognostic value. For
example, mortality is almost twice as high for all inpatients with parasitemias over
100,000/pL as for those with parasitemias less than 100,000/jlL (7.96% versus 4.40%).
Using a parasitemia cut-off of 100,000/jlL produced the greatest difference in mortality
between those above and those below the cut-off, so a parasitemia of 100,000/(J.L may
be an appropriate cut-off as an indicator of increased risk of death. But as would be
expected, clinical presentation seemed to correlate with outcome better than did
peripheral parasite density. Mortality for all KEMRI patients was more than three
times the mortality for general pediatric ward patients (6.32% versus 1.87%), and for
cerebral patients mortality was more than eight times that for pediatric ward patients
(15.75% versus 1.87%). None the less, the applicability of a cut-off "warning"
parasitemia level as an indication for aggressive inpatient monitoring and parenteral
treatment might merit further investigation.
Mortality did not vary dramatically with age for all inpatients considered
together. Flowever, cerebral malaria patients had the highest mortality for those under
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2 years of age, and all of the deaths in the malarial anemia patients occurred under 3
years of age. This may be consistent with the theory of the development of partial
strain specific immunity. If immunity is strain specific, then as people age, higher
parasitemias may be tolerated without disease. If deaths occur at only a very young
age, then we could postulate that this partial immunity protects not only against
disease, but also against severe disease, and even mortality. Thus, when young children
are exposed to strains which they have not previously encountered they are not only
more likely to become sick than are older individuals, but they are also more likely to
develop severe disease and to die. This conclusion is supported by the finding of
higher mortality at younger ages.

Disease versus Parasitemia
Distinguishing between malaria parasitization and disease is not
straightforward, and exactly what defines a "case of malaria" is a subtle point which is
still disputed. Mortality in Kilifi District follows a pattern which is typical of endemic
areas, being highest in the youngest age groups, when severe disease is most common
[9]. But again, it is of interest to note that both the risk of severe disease and the risk of
death reach their peak before the age at which the prevalence of parasites is highest.
One explanation for this is that at younger ages parasitemia is more likely to cause
disease, and that healthy children are healthy only because they are not parasitized,
whereas at older ages parasitemia is better tolerated so that the prevalence of
parasitemia in the healthy population increases. This has implications for the
relationship between parasitemia and disease because while the partial immunity which
develops over time is protective against disease it is apparently not protective against
parasitemia. However, a cross-sectional study from western Kenya has suggested that
immunity may reduce parasitemia too, in that healthy children had decreasing parasite
densities over the ages 0 to 6 years.
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In fact, it is not known how the partial immunity which develops through
chronic exposure to malaria protects against disease without eliminating parasitemia.
It may be, as discussed, that specific immunity is against parasite antigens which vary
from strain to strain [39, 40]. It is also possible to imagine that what is being
considered "partial immunity" is in part just an adaptation or a tolerance of the host to
the effects of malaria parasitization. That is, the host does not manifest the symptoms
of severe anemia (respiratory distress and heart failure) or does not, perhaps, mount the
same immune response to parasite neoantigens, or the same cytokine response to waves
of merozoites being released. This idea is consistent with the finding that immunity to
disease is developed without complete immunity to infection.
In a survey study of healthy children in western Kenya with a mean parasite
prevalence of 94.4%, a comparison of geometric mean parasite density and age revealed
that there is a significant decrease in parasite density for older children as compared
with younger ones (<2 years vs. 2-3 years vs. 4-6 years) [17]. If parasitemia declines
with age, then the "partial immunity" which these children develop is actually
reducing parasite density, not just disease. In this same study, prevalence of fever
(defined as temp >37.5 C) was found to increase with increasing parasite density, and
the authors suggest that parasite density could therefore be used as a surrogate measure
of malaria morbidity and mortality. But fever alone in an ambulatory population
represents the mildest form of disease.

While parasite density may be an appropriate

surrogate measure for mild disease and certain types of severe disease, and it may not
necessarily follow that parasite density would be a good measure of mortality. In
particular, it is not entirely clear whether the prevalence of fever is a reflection of the
incidence of cerebral malaria disease and mortality as the authors suggest. This is
because of the age distribution of cerebral malaria.
Whether the late age of onset of cerebral malaria is due to rare parasite strains
or whether prior sensitization is required to trigger cerebral malaria, it is not apparent
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how lower parasite densities in the population would confer any protection against this
form of disease. That is, whatever it is about the immunology or pathogenesis of
cerebral malaria which delays its onset relative to other forms of malaria disease, it
seems likely that this age effect would preclude a direct correlation between parasite
density in the population and cerebral malaria morbidity. If this were true, then the
correlation between parasite density and mortality might be weakened because of the
high proportion of malaria deaths due to cerebral disease.

Further Analyses to Consider
There are two factors which we did not assess in our study which would be of
interest: history of antimalarial treatment prior to presentation at the hospital and
stage of parasite development. We did not determine which patients had taken
antimalarials prior to coming to hospital. Field and Niven found a correlation
between mortality and parasitemia for those patients who had not taken chloroquine
prior to the blood film. Perhaps including a history of treatment in the analysis would
reveal stronger correlations in our data. Secondly, there is considerable evidence that a
peripheral blood film with a predominance of late stage parasites is correlated with
poor outcome and is suggestive of a greater load of sequestered parasites [12, 13, 14].
No attempt was made to assess parasite stage when the blood films for this study were
read. But again, including parasite stage in our analysis would very likely help
strengthen correlations or elucidate new correlations between parasite density and
severity of disease.
Finally, a question to ponder: why is the spectrum of childhood disease so
different in western versus coastal Kenya? Parasite prevalence is around 94% in
western Kenya and severe anemia is the most common severe form of malaria, with
cerebral malaria being relatively rare. In contrast, along the coast of Kenya parasite
prevalence is around 34% and cerebral malaria and severe anemia are both seen, but
cerebral malaria is far more common than in western Kenya. Could the differences in

spectrum of disease seen in these two areas be attributed to the difference in the force
of transmission and the different parasite rates in the two areas?

Conclusion
The search for surrogate measures of malaria morbidity and mortality
continues. Surrogate measures would facilitate evaluation of public health
interventions in that labor intensive direct measurement of disease and mortality
would be avoided. To date, no universal useful measure has been identified. Only one
study has suggested that peripheral parasitemia measured in the general population
may be of value in assessing the burden of malaria morbidity and may therefore be of
use in evaluating the effect of interventions. Similarly, prognostic indicators applicable
to individual patients are lacking. Peripheral parasitemia was shown long ago to have a
general association with severity of disease and outcome. Further studies have
attempted to elucidate combinations of clinical and laboratory assessments which
would be of prognostic value in the evaluation of patients in hospital. Yet the fact
remains that peripheral parasitemia alone is of virtually no prognostic value for the
individual patient. Our data support these findings and further reveal that while severe
disease is generally associated with higher parasitemias than is non-severe disease, those
forms of disease with the highest mortality, cerebral malaria and severe malarial
anemia, do not have significantly higher parasitemias than other severe malarial disease
and in fact may have lower parasitemias. This reduces even further the usefulness of
elevated parasitemia as a prognostic indicator of morbidity and mortality and also
indicates that parasite density is perhaps only of secondary importance in, or is perhaps
secondary to, the pathogenesis of severe disease.
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FIGURE 1

Percent of Patients by Age in Years for Outpatients versus
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